Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia-Reference-Cited by-同舟云学术

Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia

Published:2021-05 Issue:5 Volume:2 Page:515-526
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Wang Lu,Birch Noah Warren,Zhao Zibo,Nestler Carson Meredith,Kazmer Alexander,Shilati Anthony,Blake Alisha,Ozark Patrick Alexander^ORCID,Rendleman Emily Jane,Zha Didi,Ryan Caila Ann,Morgan Marc Alard Jonathan^ORCID,Shilatifard Ali^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s43018-021-00199-4.pdf

Reference41 articles.

1. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013).

2. Wang, L. et al. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nat. Med. 24, 758 (2018).

3. Wang, L. & Shilatifard, A. UTX mutations in human cancer. Cancer Cell 35, 168–176 (2019).

4. Morgan, M. A. & Shilatifard, A. Chromatin signatures of cancer. Genes Dev. 29, 238–249 (2015).

5. Rasmussen, K. D. & Helin, K. Role of TET enzymes in DNA methylation, development, and cancer. Gene Dev. 30, 733–750 (2016).

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer;European Journal of Cancer;2024-10

2. Additional Sex Combs-like Family Associated with Epigenetic Regulation;International Journal of Molecular Sciences;2024-05-08

3. Regulation of Med1 protein by overexpression of BAP1 in breast cancer cells;Molecular & Cellular Oncology;2024-05-02

4. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119;Blood Cancer Discovery;2024-02-14

5. Beyond BCR::ABL1—The Role of Genomic Analyses in the Management of CML;Journal of the National Comprehensive Cancer Network;2024-02